Per an SEC 13F filing (the quarterly “Here’s What I Bought While You Weren’t Looking” report), Bearing Point dumped a solid chunk of Sprouts in Q3. The stake’s value nosedived from representing 1.2% of fund AUM to just 0.3%. To put that in perspective: if their portfolio were a salad, Sprouts used to be the arugula. Now it’s the sad parsley garnish no one asked for.
The big reveal? Protocol fees. Yes, finally! After all these years, Uniswap’s decided to charge for something. Maybe next they’ll start monetizing the “swipe right” vibe of their interface. Groundbreaking.
Coinbase, that grand courtier of cyberspace, has decamped to Singapore with its new Business platform, a cauldron of instant USDC payments, global settlements, and tools for the crypto-toting bourgeoisie-all under the benevolent stewardship of Standard Chartered.
This reform, the most significant since Uniswap’s 2020 token launch, aims to transform UNI from a passive governance token into a deflationary, yield-generating beast. A most noble pursuit, if one can ignore the chaos it might unleash.
Visa Inc. (NYSE: V), in a move that has surely sent ripples through the drawing rooms of finance, unveiled on the 12th of November a pilot so bold, so revolutionary, it dares to allow businesses to send payouts directly to stablecoin wallets. Yes, you read correctly-stablecoin wallets. Whatever next? The announcement, made at the Web Summit in Lisbon (a place of much ado about nothing, if ever there was one), promises to streamline global transactions for creators and gig workers. How very convenient. 🌐
Oh, the sight to behold! Hardly moments ago, lawmakers from both houses danced through the masquerade of deliberation. The Democrats sung for more moolah for healthcare and other such scrumptious indulgences, whereas the Republicans, true to form, preferred to jive with the idea of simply reopening the doors first. 😂
The hapless ADA has been tossed about like a Victorian heroine in a tempest, plummeting 20% to hover near 0.57. Traders, armed with spreadsheets and existential dread, fixate on the sacred $0.50 support level, where hope-or hubris-might intervene.
Now, I’ll admit I’ve never owned a single share of CRISPR. My own portfolio resembles a thrift store bin-lots of mystery, minimal value-but I do understand the agony of watching something you love underperform. Take CRISPR’s stock price: up 0.64% over the past year while the S&P 500 zoomed past it like a Tesla on Autopilot. It’s the financial equivalent of being left at the prom while your date goes home with a blockchain ETF.
That’s right, Transak USA LLC has secured a shiny set of MTLs in Iowa, Kansas, Michigan, South Carolina, Pennsylvania, and Vermont! 🌽🍁 Now, with a grand total of 11 states on its license list, this company is ready to make stablecoin payments as easy as swiping a credit card at a vending machine. Seriously, it’s that smooth. Transak made this big announcement on Nov. 11, 2025, and you better believe they’re celebrating in style. 😎
IVV cuts its fees to a sliver-0.03% versus SPY’s 0.09%. It’s the difference between a clean knife and a rusted blade. Both yield roughly the same dividends, but the cost is a slow bleed over time. For the long-haul investor, it’s a choice between a bullet and a needle.
